公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2022 | Patient-reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate-to-severe atopic dermatitis | Thyssen, J P; Yosipovitch, G; Paul, C; Kwatra, S G; CHIA-YU CHU ; DiBonaventura, M; Feeney, C; Zhang, F; Myers, D; Rojo, R; Valdez, H | Journal of the European Academy of Dermatology and Venereology : JEADV | 26 | 22 |